Literature DB >> 24438619

Epstein-Barr virus-encoded RNAs as a survival predictor in nasopharyngeal carcinoma.

Kengjian Ke1, Haiyun Wang2, Sha Fu2, Zichen Zhang2, Liping Duan3, Dabo Liu4, Jin Ye5.   

Abstract

BACKGROUND: Epstein-Barr virus (EBV) infection is one of the most important factors of nasopharyngeal carcinoma (NPC) endemic areas. Transcription of EBV-encoded non-polyadenylated RNAs (EBERs) are presented in most of NPC tumors. Exploring EBERs as a prognostic marker for NPC might further be informative about the biology and the progression of the disease. The aim of this study was to analyze the role of EBV latency in the clinical management of nasopharyngeal carcinoma (NPC), by detecting EBERs.
METHODS: RNA in situ hybridization (ISH) for detecting EBERs was carried out on 908 NPC tumor tissues. Overall survival (OS) curves were analyzed with the Kaplan-Meier method and the Cox proportional-hazards regression models.
RESULTS: The median follow-up time was 70 months (1-120 months). Eight hundred and sixteen (89.9%) from a total of 908 consecutive NPC cases were found to be EBV-EBER positive. EBER-ISH staining revealed nuclear localization in NPC cells. In the Kaplan-Meier analysis for OS, high EBER expression levels in NPC patients were statistically significant positive prognostic factors for survival (log-rank, P = 0.022), especially in adults aged 17-40 years (P = 0.023) and in those with advanced stage disease (log-rank, P = 0.002). Cox proportional-hazards regression model analysis showed that the EBER expression level was an independent risk factor for OS (hazard ratio 0.724, P = 0.005).
CONCLUSIONS: EBERs were frequently detected in NPC tumor tissues, and high-level EBER expression correlated with good prognosis in NPC patients, especially in adult patients and in those with advanced stage disease. EBER may serve as a potential prognostic predictor in NPC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24438619

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  6 in total

Review 1.  Data Set for the Reporting of Carcinomas of the Nasopharynx and Oropharynx: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting.

Authors:  James S Lewis; David J Adelstein; Abbas Agaimy; Diane L Carlson; William C Faquin; Tim Helliwell; Jos Hille; Tony Ng; John M Nicholls; Brian O'Sullivan; Lester D R Thompson
Journal:  Arch Pathol Lab Med       Date:  2018-11-30       Impact factor: 5.534

2.  Advanced Nasopharyngeal Carcinoma with Generalized Lymphadenopathy Masquerade as Lymphoma.

Authors:  V Sha Kri Eh Dam; Nasibah Mohamad; Izyan Rifhana Muhamad; Al Duais Saleh Abdul Kadir Saeed; Wan Faiziah Wan Abdul Rahman; Faezahtul Arbaeyah Hussain; Azlan Husin; Norhafiza Mat Lazim
Journal:  Iran J Otorhinolaryngol       Date:  2022-05

3.  Paraneoplastic Limbic Encephalitis in a Male with Nasopharyngeal Carcinoma.

Authors:  Ze-Mou Yu; Wei Li; Chong-Qing Yang; Yan Song; Ding-Yi Wang; Fu-Geng Liu; Tao Gong
Journal:  Chin Med J (Engl)       Date:  2016-05-20       Impact factor: 2.628

4.  Ubiquitous Distribution of Epstein-Barr Virus and the Highly Uneven Distribution of Nasopharyngeal Carcinoma.

Authors:  Chu-Qiong Wang; Jiman He
Journal:  Chin Med J (Engl)       Date:  2016-10-20       Impact factor: 2.628

5.  Analysis of Epstein-Barr Virus (EBV) and PD-L1 Expression in Nasopharyngeal Carcinoma Patients in a Non-Endemic Region.

Authors:  Josiane M Dias; Iara V V Santana; Vinicius D da Silva; André L Carvalho; Lidia M R B Arantes
Journal:  Int J Mol Sci       Date:  2022-10-03       Impact factor: 6.208

Review 6.  Exosomes in Nasopharyngeal Carcinoma.

Authors:  Yujuan Zhou; Longzheng Xia; Jingguan Lin; Heran Wang; Linda Oyang; Shiming Tan; Yutong Tian; Min Su; Hui Wang; Deliang Cao; Qianjin Liao
Journal:  J Cancer       Date:  2018-02-11       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.